Skip to content

CLARIFLEX CLRFLXC (REF CLRFLXC240)Recalls & reported problems

Johnson & Johnson Surgical Vision, Inc. · SIL 13.0MM 6 OPT MOD C PMMA OPTIEDGE II · Class 3 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05050474501638), received between Jan 8, 2025 and Jan 8, 2025 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Opacification” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Opacification1

Patient problems

  • Foreign Body Sensation in Eye1
  • Visual Disturbances1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 8, 2025Material Opacification; Material Opacification

    A PATIENT WHO HAD CLARIFLEX LENSES IMPLANTED IN BOTH RIGHT (OD) AND LEFT (OS) EYES IN 2009 REPORTED OF EXPERIENCING SIGNIFICANT VISION ISSUES DUE TO DEPOSITS THAT HAVE FORMED ON THE INTRAOCULAR LENSES (IOLS). THE SYMPTOMS SIGNIFICANTLY INTERFERE WITH DAILY ACTIVITIES OF PATIENT. THE LENSES REMAIN IMPLANTED. ON (B)(6) 2009 (ONSET): THE PATIENT STATES OS VISUAL ACUITY (VA) SEEMS GREAT. FEELS LIKE FOREIGN BODY (FB) AND LITTLE FLICKERY. MANIFEST REFRACTION -1.25 + 0.50 X 130, 20/30. VISUALLY SIGNIFICANT CATARACT (VSC): 20/50 -2, PINHOLE (PH) 20/40. ON (B)(6) 2009: THE PATIENT STATES VA IS CLEARER IN BOTH EYES (OU), COMPLAINT OF LEFT EYE (OS) HAVING A FOREIGN BODY SENSATION (FBS) ON OUTER EDGE AT TIMES. WITHOUT CORRECTION VA <20/25-1; 20/60-2, PH 20/30-2 WITHOUT CORRECTION J-2. SLE (SLIT LAMP EVALUATION) MINOR FOLDS. MEDS AS DIRECTED FOR BOTH EYES (SYSTANE ULTRA TEARS). AS A RESULT, THE PATIENT IS SCHEDULED FOR A PROCEDURE TO EXCHANGE THE IOLS AND IMPLANT NEW LENSES. A RETINA SPECIALIST IS TO EXCHANGE THE IOLS AND SUTURE IN NEW LENSES. NO FURTHER INFORMATION WAS PROVIDED. THIS EMDR REPORT PERTAINS TO THE RIGHT EYE (OD) OF THE PATIENT. A SEPARATE REPORT WILL BE SUBMITTED FOR THE PATIENT'

    Patient problems: Foreign Body Sensation in Eye; Visual Disturbances

    MAUDE report 21099450 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page